These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
185 related articles for article (PubMed ID: 17186530)
1. Underestimation of malignancy of breast core-needle biopsy: concepts and precise overall and category-specific estimates. Houssami N; Ciatto S; Ellis I; Ambrogetti D Cancer; 2007 Feb; 109(3):487-95. PubMed ID: 17186530 [TBL] [Abstract][Full Text] [Related]
2. Atypical ductal hyperplasia: improved accuracy with the 11-gauge vacuum-assisted versus the 14-gauge core biopsy needle. Sohn V; Arthurs Z; Herbert G; Keylock J; Perry J; Eckert M; Fellabaum D; Smith D; Brown T Ann Surg Oncol; 2007 Sep; 14(9):2497-501. PubMed ID: 17564749 [TBL] [Abstract][Full Text] [Related]
3. Ductal carcinoma in situ at core-needle biopsy: meta-analysis of underestimation and predictors of invasive breast cancer. Brennan ME; Turner RM; Ciatto S; Marinovich ML; French JR; Macaskill P; Houssami N Radiology; 2011 Jul; 260(1):119-28. PubMed ID: 21493791 [TBL] [Abstract][Full Text] [Related]
4. Lobular carcinoma in situ or atypical lobular hyperplasia at core-needle biopsy: is excisional biopsy necessary? Foster MC; Helvie MA; Gregory NE; Rebner M; Nees AV; Paramagul C Radiology; 2004 Jun; 231(3):813-9. PubMed ID: 15105449 [TBL] [Abstract][Full Text] [Related]
5. US-guided 14G core needle biopsy: comparison between underestimated and correctly diagnosed breast cancers. Kim H; Youk JH; Kim JA; Gweon HM; Jung WH; Son EJ Asian Pac J Cancer Prev; 2014; 15(7):3179-83. PubMed ID: 24815467 [TBL] [Abstract][Full Text] [Related]
6. Breast cancer underestimation rate of atypical ductal hyperplasia diagnosed by core-needle biopsy under imaging guidance. Wiratkapun C; Wibulpholprasert B; Lertsithichai P; Pulpinyo K; Wongwaisayawan S J Med Assoc Thai; 2005 Apr; 88(4):460-6. PubMed ID: 16146248 [TBL] [Abstract][Full Text] [Related]
7. Predictors of invasion in patients with core-needle biopsy-diagnosed ductal carcinoma in situ and recommendations for a selective approach to sentinel lymph node biopsy in ductal carcinoma in situ. Huo L; Sneige N; Hunt KK; Albarracin CT; Lopez A; Resetkova E Cancer; 2006 Oct; 107(8):1760-8. PubMed ID: 16977650 [TBL] [Abstract][Full Text] [Related]
8. Multicenter evaluation of the breast lesion excision system, a percutaneous, vacuum-assisted, intact-specimen breast biopsy device. Sie A; Bryan DC; Gaines V; Killebrew LK; Kim CH; Morrison CC; Poller WR; Romilly AP; Schilling K; Sung JH Cancer; 2006 Sep; 107(5):945-9. PubMed ID: 16874817 [TBL] [Abstract][Full Text] [Related]
9. Predictors of underestimation of malignancy after image-guided core needle biopsy diagnosis of flat epithelial atypia or atypical ductal hyperplasia. Yu CC; Ueng SH; Cheung YC; Shen SC; Kuo WL; Tsai HP; Lo YF; Chen SC Breast J; 2015; 21(3):224-32. PubMed ID: 25772033 [TBL] [Abstract][Full Text] [Related]
10. Underestimation of DCIS at MRI-guided vacuum-assisted breast biopsy. Lee JM; Kaplan JB; Murray MP; Mazur-Grbec M; Tadic T; Stimac D; Liberman L AJR Am J Roentgenol; 2007 Aug; 189(2):468-74. PubMed ID: 17646475 [TBL] [Abstract][Full Text] [Related]
11. Atypical ductal hyperplasia on core biopsy: an automatic trigger for excisional biopsy? McGhan LJ; Pockaj BA; Wasif N; Giurescu ME; McCullough AE; Gray RJ Ann Surg Oncol; 2012 Oct; 19(10):3264-9. PubMed ID: 22878619 [TBL] [Abstract][Full Text] [Related]
12. Underestimation Rate at MR Imaging-guided Vacuum-assisted Breast Biopsy: A Multi-Institutional Retrospective Study of 1509 Breast Biopsies. Verheyden C; Pages-Bouic E; Balleyguier C; Cherel P; Lepori D; Laffargue G; Doutriaux I; Jalaguier A; Poncelet E; Millet I; Thomassin-Naggara I; Taourel P Radiology; 2016 Dec; 281(3):708-719. PubMed ID: 27355898 [TBL] [Abstract][Full Text] [Related]
13. Ductal carcinoma in situ diagnosed at US-guided 14-gauge core-needle biopsy for breast mass: preoperative predictors of invasive breast cancer. Park AY; Gweon HM; Son EJ; Yoo M; Kim JA; Youk JH Eur J Radiol; 2014 Apr; 83(4):654-9. PubMed ID: 24534119 [TBL] [Abstract][Full Text] [Related]
14. Atypical ductal hyperplasia and ductal carcinoma in situ as revealed by large-core needle breast biopsy: results of surgical excision. Darling ML; Smith DN; Lester SC; Kaelin C; Selland DL; Denison CM; DiPiro PJ; Rose DI; Rhei E; Meyer JE AJR Am J Roentgenol; 2000 Nov; 175(5):1341-6. PubMed ID: 11044038 [TBL] [Abstract][Full Text] [Related]
15. Predictors of residual invasive disease after core needle biopsy diagnosis of ductal carcinoma in situ. Rutstein LA; Johnson RR; Poller WR; Dabbs D; Groblewski J; Rakitt T; Tsung A; Kirchner T; Sumkin J; Keenan D; Soran A; Ahrendt G; Falk JS Breast J; 2007; 13(3):251-7. PubMed ID: 17461899 [TBL] [Abstract][Full Text] [Related]
16. [Breast calcifications with percutaneous vacuum-assisted biopsy diagnosis of malignancy or atypical hyerplasia: correlations with surgical findings]. Piubello Q; Montemezzi S; D'Atri C Pathologica; 2002 Dec; 94(6):299-305. PubMed ID: 12540993 [TBL] [Abstract][Full Text] [Related]
17. Is core needle biopsy superior to fine-needle aspiration biopsy in the diagnosis of papillary breast lesions? Masood S; Loya A; Khalbuss W Diagn Cytopathol; 2003 Jun; 28(6):329-34. PubMed ID: 12768640 [TBL] [Abstract][Full Text] [Related]
18. Factors associated with upstaging from ductal carcinoma in situ following core needle biopsy to invasive cancer in subsequent surgical excision. Kim J; Han W; Lee JW; You JM; Shin HC; Ahn SK; Moon HG; Cho N; Moon WK; Park IA; Noh DY Breast; 2012 Oct; 21(5):641-5. PubMed ID: 22749854 [TBL] [Abstract][Full Text] [Related]
19. Factors that impact the upgrading of atypical ductal hyperplasia. Gümüş H; Mills P; Gümüş M; Fish D; Jones S; Jones P; Devalia H; Sever A Diagn Interv Radiol; 2013; 19(2):91-6. PubMed ID: 23019055 [TBL] [Abstract][Full Text] [Related]
20. Accuracy and underestimation of malignancy of breast core needle biopsy: the Florence experience of over 4000 consecutive biopsies. Ciatto S; Houssami N; Ambrogetti D; Bianchi S; Bonardi R; Brancato B; Catarzi S; Risso GG Breast Cancer Res Treat; 2007 Mar; 101(3):291-7. PubMed ID: 16823506 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]